Prognostic value of a high level of circulating endothelial cells in patients with HER2-recurrent or metastatic breast cancer treated with bevacizumab in combination with paclitaxel and gemcitabine as first-line therapy

Saved in:

Bibliographic Details
Published in:	Breast cancer research : BCR Vol. 13; no. Suppl 2; p. P4
Main Authors:	Manso, L, Ciruelos, E, Codes, M, De la Haba, J, Galan, A, Baena, J, Jaen, A, Gil, M, Murias, A, Blancas, I, Gonzalez, E, Perez, D, Bayo, JL, Mel, J, Garcia-Martinez, E, Cubedo, R, Salvador, J
Format:	Journal Article
Language:	English
Published:	BioMed Central Ltd 16-11-2011 BioMed Central
Subjects:	Antineoplastic agents Breast cancer Cancer metastasis Care and treatment Development and progression Endothelium Poster Presentation Prognosis Recurrence (Disease)
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
ISSN:	1465-542X 1465-5411 1465-542X
DOI:	10.1186/bcr3025